Gilead Sciences to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Truist Securities Downgrades Gilead Sciences (GILD) to Hold
February 22, 2024 6:04 AM ESTTruist Securities analyst Robyn Karnauskas downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Hold with a price target of $82.00 (from $91.00).
The analyst comments "We view GILD/RCUS (RCUS, Buy) re-strategizing to focus on chemo combos in lung and other lrg markets as smart,... More
